| The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene DS Waddell, LM Baehr, J Van Den Brandt, SA Johnsen, HM Reichardt, ... American Journal of Physiology-Endocrinology and Metabolism 295 (4), E785-E797, 2008 | 407 | 2008 |
| The histone H2B-specific ubiquitin ligase RNF20/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expression E Shema, I Tirosh, Y Aylon, J Huang, C Ye, N Moskovits, N Raver-Shapira, ... Genes & development 22 (19), 2664-2676, 2008 | 307 | 2008 |
| Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer E Hessmann, MS Patzak, L Klein, N Chen, V Kari, I Ramu, TE Bapiro, ... Gut 67 (3), 497-507, 2018 | 206 | 2018 |
| Estrogen receptor isoform‐specific regulation of endogenous gene expression in human osteoblastic cell lines expressing either ERα or ERβ DG Monroe, BJ Getz, SA Johnsen, BL Riggs, S Khosla, TC Spelsberg Journal of cellular biochemistry 90 (2), 315-326, 2003 | 198 | 2003 |
| Stem-cell-like properties and epithelial plasticity arise as stable traits after transient Twist1 activation JM Schmidt, E Panzilius, HS Bartsch, M Irmler, J Beckers, V Kari, ... Cell reports 10 (2), 131-139, 2015 | 197 | 2015 |
| TGFβ inducible early gene enhances TGFβ/Smad-dependent transcriptional responses SA Johnsen, M Subramaniam, R Janknecht, TC Spelsberg Oncogene 21 (37), 5783-5790, 2002 | 185 | 2002 |
| CDK9 directs H2B monoubiquitination and controls replication‐dependent histone mRNA 3′‐end processing J Pirngruber, A Shchebet, L Schreiber, E Shema, N Minsky, RD Chapman, ... EMBO reports 10 (8), 894-900, 2009 | 180 | 2009 |
| HDAC inhibitor–dependent transcriptome and memory reinstatement in cognitive decline models E Benito, H Urbanke, B Ramachandran, J Barth, R Halder, A Awasthi, ... The Journal of clinical investigation 125 (9), 3572-3584, 2015 | 175 | 2015 |
| Bromodomain protein BRD4 is required for estrogen receptor-dependent enhancer activation and gene transcription S Nagarajan, T Hossan, M Alawi, Z Najafova, D Indenbirken, U Bedi, ... Cell reports 8 (2), 460-469, 2014 | 174 | 2014 |
| Estrogen-dependent gene transcription in human breast cancer cells relies upon proteasome-dependent monoubiquitination of histone H2B T Prenzel, Y Begus-Nahrmann, F Kramer, M Hennion, C Hsu, T Gorsler, ... Cancer research 71 (17), 5739-5753, 2011 | 168 | 2011 |
| The histone H2B monoubiquitination regulatory pathway is required for differentiation of multipotent stem cells O Karpiuk, Z Najafova, F Kramer, M Hennion, C Galonska, A König, ... Molecular cell 46 (5), 705-713, 2012 | 149 | 2012 |
| The ubiquitin ligase Rnf6 regulates local LIM kinase 1 levels in axonal growth cones B Tursun, A Schlüter, MA Peters, B Viehweger, HP Ostendorff, ... Genes & development 19 (19), 2307-2319, 2005 | 142 | 2005 |
| TIEG1 null mouse-derived osteoblasts are defective in mineralization and in support of osteoclast differentiation in vitro M Subramaniam, G Gorny, SA Johnsen, DG Monroe, GL Evans, ... Molecular and cellular biology 25 (3), 1191-1199, 2005 | 140 | 2005 |
| Antitumor Effects of a Combined 5-Aza-2′Deoxycytidine and Valproic Acid Treatment on Rhabdomyosarcoma and Medulloblastoma in Ptch Mutant Mice I Ecke, F Petry, A Rosenberger, S Tauber, S Mönkemeyer, I Hess, ... Cancer research 69 (3), 887-895, 2009 | 134 | 2009 |
| Epigenetic plasticity: a central regulator of epithelial-to-mesenchymal transition in cancer U Bedi, VK Mishra, D Wasilewski, C Scheel, SA Johnsen Oncotarget 5 (8), 2016, 2014 | 133 | 2014 |
| Chemoradiotherapy resistance in colorectal cancer cells is mediated by Wnt/β-catenin signaling G Emons, M Spitzner, S Reineke, J Möller, N Auslander, F Kramer, Y Hu, ... Molecular Cancer Research 15 (11), 1481-1490, 2017 | 130 | 2017 |
| Epigenetic treatment of pancreatic cancer: is there a therapeutic perspective on the horizon? E Hessmann, SA Johnsen, JT Siveke, V Ellenrieder Gut 66 (1), 168-179, 2017 | 122 | 2017 |
| Selection of patients for long-term surveillance with digital dermoscopy by assessment of melanoma risk factors HA Haenssle, B Korpas, C Hansen-Hagge, T Buhl, KM Kaune, S Johnsen, ... Archives of dermatology 146 (3), 257-264, 2010 | 114 | 2010 |
| Loss of CHD1 causes DNA repair defects and enhances prostate cancer therapeutic responsiveness V Kari, WY Mansour, SK Raul, SJ Baumgart, A Mund, M Grade, H Sirma, ... EMBO reports 17 (11), 1609-1623, 2016 | 110 | 2016 |
| MDM2 associates with polycomb repressor complex 2 and enhances stemness-promoting chromatin modifications independent of p53 M Wienken, A Dickmanns, A Nemajerova, D Kramer, Z Najafova, M Weiss, ... Molecular cell 61 (1), 68-83, 2016 | 110 | 2016 |
